$FTK

Flotek raises 2026 revenue guidance to $360-370M, Adjusted EBITDA to $50-54M

Flotek Industries Inc. raised its 2026 revenue guidance to $360-370M from $340-350M and adjusted EBITDA guidance to $50-54M. Q2 revenue was $99.4M, up 70% YoY, with adjusted EBITDA at $16.8M, up 109% YoY. International chemistry sales surged, with Q2 revenue at $10.6M and potential for 2H26 sales to exceed $40M. The company updated its corporate presentation for the Lake Street investor conference.

Original reporting
Published Sep 9, 2026, 11:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 2:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Flotek raises 2026 revenue guidance to $360-370M, Adjusted EBITDA to $50-54M — source image
Decision brief

The 30-second read

$FTKBullishMed
01

Why it matters

The guidance lift signals stronger growth trajectory, likely prompting analysts to revise forecasts.

02

Market read

Guidance update is a primary catalyst for FTK's stock, with potential spill‑over to the broader chemicals sector.

03

What to watch

Potential supply‑chain constraints or raw‑material cost volatility not addressed.

Relevance 7/10Novelty 8/10Timing: SEC filing Sep 9 2026

Background

Flotek Industries Inc. (FTK) filed an 8‑K on Sep 9 2026 announcing updated 2026 guidance and recent Q2 results.

Company-level read

Ticker impact

$FTKBullishHigh confidence
Context

Flotek raised its 2026 revenue guidance to $360‑370M and Adjusted EBITDA to $50‑54M in a fresh SEC 8‑K filing.

Expected impact

Potential price appreciation as investors re‑price higher earnings expectations.

Evidence & confidence

The company disclosed a material increase in both revenue and EBITDA guidance, a primary catalyst for valuation.

Market effects

Higher guidance may lift peers in specialty chemicals and industrial solvents.

Positive for U.S. industrial sector sentiment.

Limited to investors tracking mid‑cap industrials.

Counterpoint

Guidance could be overly optimistic if demand peaks are temporary.

Key entities

  • Flotek Industries Inc.

    Specialty chemicals producer.

Related articles

$FTKHigh

Flotek gets EPA approval for VeraCAL flare monitoring at oil refineries (FTK:NYSE)

Flotek Industries (FTK) announced EPA approval for its VeraCAL optical system as a substitute for gas chromatography in measuring flare vent gas composition and net heating value at oil refineries. The company stated this positions it to address environmental and operational challenges in the industry. According to Flotek, the approval is expected to drive growth and expand its market opportunities.

$FTKHighAI 8/10

Flotek Receives EPA Approval For VeraCAL Flare Monitoring At Petroleum Refineries

Flotek Industries (NYSE: FTK) announced EPA approval for its VeraCAL system, allowing it to measure flare vent gas composition in petroleum refineries. The approval, published as Alternative Test Method 163, is expected to expand Flotek's Data Analytics business and create new opportunities. Flotek believes VeraCAL's continuous, near real-time measurements will support refinery compliance and operations.

$FTKMed

Flotek Secures $120 Million Senior Secured Term Loan to Support Continued Strategic Growth

Flotek Industries (NYSE: FTK) secured a $120 million senior secured term loan, with $75 million available immediately and up to $45 million in delayed-draw commitments. The funds will support capital expenditures, refinance existing debt, and fund working capital. The loan matures in 2031, with no amortization required for the first two years. Elda River Capital Management is the lead lender.